A recent study from Sweden highlights a concerning association between taking erectile dysfunction (ED) drugs and nitrates for angina (chest pain), revealing an elevated risk of cardiovascular events and mortality.
Dangerous Duo – Understanding the Risk
Combining ED medications with nitrates doubles their blood-vessel dilating effects, leading to a significant drop in blood pressure. Analysis of data from 61,487 men in the Swedish Patient Register revealed that those taking both medications were at a 39% higher risk of general mortality, 34% higher risk of cardiovascular mortality, and a 40% higher risk of non-cardiovascular mortality compared to those on nitrates alone.
Moreover, this combination increased the likelihood of heart attack by 72%, heart failure by 67%, the need for cardiac revascularization by 95%, and major cardiac events by 70%.
Erectile Dysfunction is a Warning
ED serves as more than a mere sexual concern; it acts as an early indicator of potential heart health issues. Cardiologists emphasize that both ED and cardiovascular problems share a common thread – vascular disease, a combination of atherosclerosis and endothelial dysfunction. Understanding these processes is crucial in comprehending the interconnected nature of these health issues.
Navigating Treatment Challenges and Alternatives
The conflict arises due to the dual blood-vessel dilating effects of phosphodiesterase-5 inhibitors (PDE5i) for ED and nitrates in the management of angina. Experts highly recommend that healthcare providers choose one or the other to prevent a dangerous drop in blood pressure.
Alternative treatments for angina, avoiding the use of nitrates, include various antianginal therapies and lifestyle changes. Addressing obesity, a common precursor to both ED and cardiovascular issues, is one such lifestyle modification that can positively impact both conditions.
In conclusion, while patients may face challenges in keeping track of their medications, healthcare providers play a crucial role in educating and monitoring drug interactions. A collaborative effort between physicians and pharmacists is essential to enhance patient safety, particularly when it comes to the known risks associated with the combination of nitrates and medications used to treat ED.
ED: erectile dysfunction; PDE5i: phosphodiesterase-5 inhibitor
Reference: Trolle Lagerros Y, Grotta A, Freyland S, Grannas D, Andersson DP. Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors. J Am Coll Cardiol. 2024;83(3):417-426. doi:10.1016/j.jacc.2023.10.041
Link to the research paper: https://doi.org/10.1016/j.jacc.2023.10.041
Link to the original article: Click here
Enjoy Free Shipping for Limited Time only, visit POM Marketplace now!
Login or Sign Up for an account today!
* Access to POM Marketplace is available to qualified healthcare professionals only.
Disclaimer: The information provided on this website is intended for educational purposes only, and while we strive for accuracy, POMConnect assumes no liability for errors or omissions. The opinions expressed in this article are those of the author and do not necessarily reflect the views or opinions of POMConnect or its affiliated organizations. The content should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider regarding any medical concerns. POMConnect does not endorse specific treatments or external websites linked from this site. POM Marketplace is accessible exclusively to qualified healthcare professionals. Any unauthorized access or use by individuals who do not meet this criteria is prohibited.
